IMARC Group’s latest report, titled “Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, finds that the global active pharmaceutical ingredients market size reached US$ 186.6 Billion in 2019. Active pharmaceutical ingredients (APIs) are the biologically active components of a pharmaceutical drug. They are manufactured through a variety of processes such as chemical synthesis, recombinant DNA, fermentation, isolation, and recovery from natural sources. At present, many governments, especially in developing economies, are promoting the domestic production of APIs to reduce dependence on foreign supply.
Request Free Sample Report: https://www.imarcgroup.com/active-pharmaceutical-ingredients-market/requestsample
Global Active Pharmaceutical Ingredients Market Trends:
The increasing prevalence of chronic diseases is the primary factor that has led to an increase in the demand for drugs, which in turn has augmented the growth of the global API industry. Moreover, several manufacturers are investing in research and development (R&D) activities to produce better-quality, low-cost APIs that can help in the treatment of diseases beyond the scope of small molecule drugs. Apart from this, pharmaceutical companies are shifting their manufacturing facilities, as well as outsourcing their operations to developing countries for increasing production and reducing input costs. Moreover, the demand for generic APIs is expected to increase significantly as blockbuster drugs worth several billion dollars are projected to lose patent protection in the coming years. Looking forward, the market value is anticipated to reach US$ 258.8 Billion by 2025, expanding at a CAGR of 5.6% during 2020-2025.
Market Breakup by Drug Type:
- Innovative Active Pharmaceutical Ingredients
- Generic Active Pharmaceutical Ingredients
Market Breakup by Therapeutic Application:
- Cardiovascular and Respiratory
- Central Nervous System Disorders
- Neurological Disorders
Market Breakup by Synthesis:
- Synthetic Active Pharmaceutical Ingredients Type
- Innovative Synthetic APIs
- Generic Synthetic APIs
- Biotech Active Pharmaceutical Ingredients Type
- Innovative Biotech APIs
- Biotech Active Pharmaceutical Ingredients Product
- Monoclonal Antibodies
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
- Biotech Active Pharmaceutical Ingredients Expression System
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
On the basis of the type of manufacturers, captive manufacturers exhibit a clear dominance in the market, followed by merchant API manufacturers.The market has been segregated based on the type of synthesis into synthetic and biotech APIs. At present, synthetic APIs account for the largest market share.
Region-wise, North America enjoys the leading position in the market. Other major regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape with Key Player:
- Pfizer Inc.
- Novartis International AG
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Teva Pharmaceutical Industries Ltd.
- ELI Lilly and Company
- Merck & Co. Inc.
- Abbvie Inc.
Ask Analyst For Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/active-pharmaceutical-ingredients-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Other Report By IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800